- Home
- VXRT vs FATE Comparison
VXRT vs FATE Comparison
Compare VXRT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- FATE
- Stock Information
- Founded
- VXRT N/A
- FATE 2007
- Country
- VXRT United States
- FATE United States
- Employees
- VXRT N/A
- FATE N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VXRT Health Care
- FATE Health Care
- Exchange
- VXRT Nasdaq
- FATE Nasdaq
- Market Cap
- VXRT 119.0M
- FATE 108.2M
- IPO Year
- VXRT N/A
- FATE 2013
- Fundamental
- Price
- VXRT $0.41
- FATE $0.79
- Analyst Decision
- VXRT Strong Buy
- FATE Hold
- Analyst Count
- VXRT 2
- FATE 9
- Target Price
- VXRT $3.00
- FATE $5.50
- AVG Volume (30 Days)
- VXRT 1.7M
- FATE 1.9M
- Earning Date
- VXRT 03-20-2025
- FATE 03-05-2025
- Dividend Yield
- VXRT N/A
- FATE N/A
- EPS Growth
- VXRT N/A
- FATE N/A
- EPS
- VXRT N/A
- FATE N/A
- Revenue
- VXRT $28,700,000.00
- FATE $13,631,000.00
- Revenue This Year
- VXRT N/A
- FATE N/A
- Revenue Next Year
- VXRT $48.02
- FATE N/A
- P/E Ratio
- VXRT N/A
- FATE N/A
- Revenue Growth
- VXRT 288.94
- FATE N/A
- 52 Week Low
- VXRT $0.39
- FATE $0.76
- 52 Week High
- VXRT $1.34
- FATE $7.35
- Technical
- Relative Strength Index (RSI)
- VXRT 30.14
- FATE 33.50
- Support Level
- VXRT $0.49
- FATE $0.83
- Resistance Level
- VXRT $0.60
- FATE $0.96
- Average True Range (ATR)
- VXRT 0.05
- FATE 0.07
- MACD
- VXRT -0.01
- FATE 0.00
- Stochastic Oscillator
- VXRT 9.77
- FATE 11.15
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.